Blood Platelets Market Trends

  • Report ID: 4719
  • Published Date: Jul 31, 2024
  • Report Format: PDF, PPT

Blood Platelets Market Trends

Growth Drivers

  • Increasing Geriatric Population – The aging population is more prone to conditions requiring platelet transfusion such as cancer, cardiovascular disease, and chronic liver disease. As the global population ages, the demand for blood platelets is anticipated to grow due to the high prevalence of age-related health issues.
  • Growing Prevalence of Blood-Related Disorder - With the growing prevalence of chronic blood disorders such as hemophilia, myelofibrosis, and thrombocytopenia, the demand for platelets is growing. As these conditions demand regular platelet transfusion to manage bleeding episodes. Around 324,648 out of 5.5 billion people worldwide have an identified bleeding disorder, reported as by the World Federation of Hemophilia's 2019 annual global survey. 
  • Surge in Number of Surgical Procedures - The increasing number of surgical procedures worldwide also contributes to the increased need for blood platelets. The increase in orthopedic and cardiac surgeries has increased the need for platelets in hospitals. In addition, increased organ transplantation such as kidney, corneal implants, and others has increased the demand for platelets. Recorded by World Observatory on Donations and Transplants, 153,863 organs were transplanted annually in 2019, which is an increase of 4.8% from 2018. 

Challenges

  • High Risk Related to the Transmission of Infections - Blood transfusions comprise significant health risks. Among these, transmission of infectious organisms remains one of the most concerning complications. Hepatitis B used to be the biggest transfusion risk. Also, there may be a chance of wrong blood group typing while transferring the blood to the patients. However, unnecessary blood transfusions should be avoided to reduce the risk of infection and other complications.  
  • High Treatment Cost Associated
  • Shortage of Blood Donors

Blood Platelets Market: Key Insights

Base Year

2023

Forecast Year

2023 – 2036

CAGR

3.7%

Base Year Market Size (2023)

USD 5.39 Billion

Forecast Year Market Size (2036)

USD 8.65 Billion

Regional Synopsis

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4719
  • Published Date: Jul 31, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of blood platelets is assessed at USD 5.57 Billion.

The blood platelets market size was over USD 5.39 Billion in 2023 and is likely to reach USD 8.65 Billion by the end of 2036, growing at around 3.7% CAGR during the forecast period i.e., between 2024-2036. The increasing prevalence of blood-related disease and the increasing geriatric population is estimated to boost the market growth.

North America region is predicted to hold at 35% of the revenue share by 2036, driven by increased demand for blood transfusion along with rising number of accidents in the region.

Aggredyne Inc., Sysmex Corporation, Haemochrom Diagnostics GmbH, Eurobio Scientific, LABiTec Labor BioMedical Technologies GmbH, Thermo Fisher Scientific Inc., PerkinElimer Inc., Werfen, S.A., F. Hoffmann-La Roche Ltd., Terumo Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample